Maohua Chen

ORCID: 0000-0002-0812-2729 · 1 paper in corpus · active 2025

Study types

  • other 1

Condition tags

  • endometriosis 1
other 2025
International journal of cancer ·doi:10.1002/ijc.35193

Tamoxifen (TAM), a selective estrogen receptor (ER) modulator, has received approval for use in patients with breast cancer (BC) exhibiting positive ER expression. Given the widespread clinical use of TAM, a comprehensive real-world study o…